4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001178913-20-001105
10% owner bought 120,000 shares at $16.00 ($1,920,000)
- 10% owner acquired 1,893,102 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Arkin Bio Ventures Limited Partnership · 10% owner
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-04-13 | Conversion : show line 1 in the form | +1,382,295 | 1,382,295 | D | ||
| 2020-04-13 | Conversion : show line 2 in the form | +343,270 | 1,725,565 | D | ||
| 2020-04-13 | Conversion : show line 3 in the form | +167,537 | 1,893,102 | D | ||
| 2020-04-13 | Purchase : show line 4 in the form | +120,000 | $16.00 | $1,920,000 | 2,013,102 | D |
| Open-market purchases · 120,000 sh · avg $16.00 · $1,920,000 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-04-13 | Conversion : show line 5 in the form Series A Preferred Stock | −1,382,295 | 0 | D |
| 2020-04-13 | Conversion : show line 6 in the form Series B-1 Preferred Stock | −343,270 | 0 | D |
| 2020-04-13 | Conversion : show line 7 in the form Series C Preferred Stock | −167,537 | 0 | D |
Loading xslF345X03/zk2024260.xml…